PGEN Precigen, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 4, 2026
$8,54
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$2,9952 haftanın en düşüğü
$8,9852 haftanın en yükseği
Piyasa Değeri (MRQ)
$3.06B
P/E
-6.3
Hisse Başına Kâr
$-1.37
Gelir
$10M
rozetleriniz
52 Haftlık Aralık
$3–$9
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$14
P/E
-6.3
ROE
3159.1%
Net Kâr Marjı
-2588.2%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PGEN Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$8.54
Piyasa Değeri (MRQ)
$3.06B
P/E
-6.3
Hisse Başına Kâr
$-1.37
Gelir
$10M
ROE
3159.1%
D/E Borç/Özsermaye (MRQ)
2.2
52 Haftlık Aralık
$3–$9
PGEN Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Precigen, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.
## History
In 2015, Intrexon purchased Oxitec, a maker of genetically sterile insects, for $160 million. In April 2019, Intrexon formed a subsidiary called Precigen, with a focus on human gene therapy. Precigen went on to win orphan drug status from the FDA for a CAR-T based therapy (investigational drug name PRGN-3006) to treat acute myeloid leukemia. In early 2020, Intrexon adopted the name of its subsidiary, Precigen, and narrowed its focus to human gene editing. With the change in name the CEO of subsidiary Precigen, Helen Sabzevari, took over leadership of the company from Randal J. Kirk.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealthcare
endüstriBiotechnology
çalışanlar160
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$10M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-1.372019-12-31 → 2025-12-31
Serbest Nakit Akışı$-90M2016-12-31 → 2025-12-31
Net kar marjı-2588.2%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PGEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -6.35Y ort. ≈-1.2 | ≈-1.2 | · | · | |
| P/S (F/S) | 313.95Y ort. ≈72.8 | ≈72.8 | 33.5 | Aşırı değerli | |
| F/D (MRQ) | 70.25Y ort. ≈26.8 | ≈26.8 | 4.5 | Aşırı değerli | |
| EV / EBITDA | -28.35Y ort. ≈25.0 | ≈25.0 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -26.55Y ort. ≈-11.1 | ≈-11.1 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -26.85Y ort. ≈-11.8 | ≈-11.8 | · | · | |
| EV / Revenue (EV / Gelir) | 313.45Y ort. ≈74.0 | ≈74.0 | · | · | |
| EV / FCF (TTM) | -27.05Y ort. ≈-11.3 | ≈-11.3 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | 74.55Y ort. ≈131.6 | ≈131.6 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PGEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Operating Margin (Faaliyet Kâr Marjı) | -1141.1% | · | 12.3% | En üst düzey | |
| EBITDA Margin (FAVÖK Marjı) | -1108.1%5Y ort. ≈-351.6% | ≈-351.6% | 12.3% | En üst düzey | |
| Pretax Margin (Vergi Öncesi Kar Marjı) | -2588.2%5Y ort. ≈-992.9% | ≈-992.9% | 15.1% | En üst düzey | |
| Net Profit Margin (Net Kâr Marjı) | -2588.2%5Y ort. ≈-857.2% | ≈-857.2% | 10.2% | En üst düzey | |
| ROA | -166.7%5Y ort. ≈-61.4% | ≈-61.4% | -18.5% | Zayıf | |
| ROE | 3159.1%5Y ort. ≈1034.3% | ≈1034.3% | -8.4% | En üst düzey | |
| ROIC | -96.9% | · | -31.0% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PGEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 2.25Y ort. ≈2.2 | ≈2.2 | · | · | |
| Cari Oran (MRQ) | 4.65Y ort. ≈3.0 | ≈3.0 | 6.5 | Düşük likidite | |
| Cari Oran (MRQ) | 3.85Y ort. ≈2.5 | ≈2.5 | 6.1 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | 2.25Y ort. ≈2.1 | ≈2.1 | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PGEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 146.7%5Y ort. ≈13.2% | ≈13.2% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -28.9%5Y ort. ≈-35.3% | ≈-35.3% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | -21.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PGEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.15Y ort. ≈0.2 | ≈0.2 | 0.1 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 4.05Y ort. ≈11.0 | ≈11.0 | 7.1 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$60.5K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-66.6%
Sonraki Rapor
Kas 11, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $0.05 | $-0.01 | 467.6% |
| 31 Mart 2026 | May 13, 2026 | $-0.02 | $-0.03 | 38.7% |
| 31 Aralık 2025 | $-0.07 | $-0.09 | 17.6% | |
| 30 Eylül 2025 | $-1.06 | $-0.10 | -993.9% | |
| 30 Haziran 2025 | $-0.09 | $-0.08 | -6.8% | |
| 31 Mart 2025 | $-0.07 | $-0.08 | 14.2% | |
| 31 Aralık 2024 | $-0.06 | $-0.06 | -4.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | $6M | $27M | $14M | $32M | $91M | $151M | $231M | $191M | $174M | $72M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $33M | $38M | $41M | $11M | |
| R&D Expense | $41M | $53M | $49M | · | · | · | · | $405M | $143M | $112M | $147M | $59M | |
| SG&A Expense | $70M | $41M | $40M | · | · | · | · | $138M | $146M | $142M | $109M | $64M | |
| Operating Expenses | $120M | $139M | $106M | · | · | · | · | $666M | $369M | $316M | $320M | $142M | |
| Operating Income | $-111M | $-135M | $-100M | · | · | · | · | $-506M | $-138M | $-125M | $-147M | $-70M | |
| Interest Expense | · | · | · | · | · | · | · | $9M | $611.0K | $861.0K | $1M | $666.0K | |
| Other Non-op | $43.0K | $6M | $627.0K | · | · | · | · | $630.0K | $1M | $2M | $1M | $-168.0K | |
| Pretax Income | $-251M | $-128M | $-96M | $-80M | $-111M | $-105M | $-171M | $-396M | $-78M | $-194M | $-87M | $-86M | |
| Income Tax | $3.0K | $-2M | $-458.0K | $-189.0K | $-160.0K | $-82.0K | $-930.0K | $-15M | $2M | $-4M | $1M | $-103.0K | |
| Net Income | $-251M | $-126M | $-96M | $28M | $-92M | $-171M | $-322M | $-509M | $-117M | $-187M | $-84M | $-82M | |
| EPS (Basic) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | · | · | · | · | · | |
| EPS (Diluted) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | · | · | · | · | · | |
| Shares (Basic) | 312,980,562 | 267,727,426 | 244,536,221 | 200,360,821 | 197,759,900 | 167,065,539 | 154,138,774 | · | · | · | · | · | |
| Shares (Diluted) | 312,980,562 | 267,727,426 | 244,536,221 | 200,360,821 | 197,759,900 | 167,065,539 | 154,138,774 | · | · | · | · | · | |
| EBITDA | $-107M | · | · | $11M | $14M | $18M | $25M | $-472M | $-107M | $-101M | · | $-60M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $30M | $8M | $5M | $36M | $52M | $66M | $97M | $68M | $63M | $136M | $27M | |
| Short-term Investments | $68M | $68M | $55M | $51M | $72M | $48M | $9M | $120M | $6M | $175M | $103M | $88M | |
| Receivables | $4M | $926.0K | $902.0K | $978.0K | $1M | $16M | $21M | $21M | $20M | $22M | $25M | $15M | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $7M | $6M | $5M | $7M | $7M | $7M | $4M | |
| Current Assets | $115M | $102M | $69M | $118M | $157M | $149M | $235M | $285M | $154M | $315M | $324M | $175M | |
| PP&E (Net) | $14M | $14M | $7M | $7M | $9M | $35M | $44M | $87M | $113M | $65M | $43M | $38M | |
| PP&E (Gross) | $38M | $37M | $31M | $31M | $30M | $70M | $80M | $136M | $158M | $99M | $69M | $60M | |
| Accum. Depreciation | $24M | $23M | $24M | $23M | $21M | $35M | $36M | $49M | $46M | $34M | $26M | $22M | |
| Goodwill | $15M | $19M | $27M | $37M | $38M | $54M | $54M | $94M | $94M | $157M | $165M | $101M | |
| Intangibles | $3M | $4M | $41M | $44M | $52M | $65M | $68M | $89M | $233M | $226M | $248M | $66M | |
| Other Non-current Assets | $908.0K | $371.0K | $767.0K | $1M | $936.0K | $2M | $1M | $2M | $4M | $4M | $4M | $1M | |
| Total Assets | $156M | $145M | $151M | $216M | $360M | $315M | $456M | $716M | $847M | $949M | $982M | $576M | |
| Accounts Payable | $12M | $4M | $2M | $4M | $3M | $5M | $6M | $12M | $9M | $8M | $5M | $6M | |
| Short-term Debt | · | · | $0 | $43M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $37M | $22M | $23M | $79M | $35M | $42M | $123M | $62M | $80M | $95M | $76M | $47M | |
| Capital Leases | $4M | $5M | $6M | $7M | $9M | $8M | $10M | $0 | · | · | · | · | |
| Deferred Tax | · | $0 | $2M | $2M | $3M | $3M | $3M | $4M | $16M | $17M | $22M | $0 | |
| Other Non-current Liabilities | $134.0K | $0 | · | · | $50.0K | $100.0K | $0 | $3M | $3M | $4M | $795.0K | $699.0K | |
| Total Liabilities | $135M | $79M | $33M | $90M | $253M | $247M | $384M | $337M | $300M | $380M | $277M | $167M | |
| Long-term Debt | $93M | $0 | · | $43M | $180M | $172M | $218M | $212M | $8M | $8M | $9M | $10M | |
| Total Debt | $93M | · | · | $43M | $183M | $172M | $218M | $212M | $8M | $8M | · | $10M | |
| Paid-in Capital | $2.36B | $2.13B | $2.08B | $2.00B | $2.02B | $1.89B | $1.75B | $1.72B | $1.40B | $1.33B | $1.25B | $843M | |
| Retained Earnings | $-2.34B | $-2.09B | $-1.96B | $-1.87B | $-1.92B | $-1.82B | $-1.65B | $-1.33B | $-848M | $-729M | $-543M | $-458M | |
| AOCI | $7.0K | $12.0K | $-2M | $-3M | $203.0K | $4M | $-27M | $-29M | $-16M | $-36M | $-13M | $-4.0K | |
| Stockholders' Equity | $21M | $39M | $118M | $126M | $107M | $67M | $72M | $363M | $534M | $560M | $694M | $385M | |
| Liabilities + Equity | $156M | $145M | $151M | $216M | $360M | $315M | $456M | $716M | $847M | $949M | $982M | $576M | |
| Shares Outstanding | 353,910,926 | 292,869,097 | 248,919,096 | 208,150,021 | 206,739,874 | 187,663,207 | 163,274,880 | 160,020,466 | 122,087,040 | 118,688,770 | 116,658,886 | 100,557,932 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $5M | $7M | $11M | $14M | $18M | $25M | $33M | $31M | $25M | $18M | $10M | |
| Stock-based Comp | $11M | $9M | $10M | $10M | $14M | $18M | $19M | $36M | $42M | $42M | $39M | $22M | |
| Deferred Tax | $0 | $-2M | $-479.0K | $-150.0K | $-167.0K | $-156.0K | $-4M | $-21M | $-3M | $-3M | $1M | $0 | |
| Amort. of Intangibles | $1M | $3M | $5M | $5M | $5M | $5M | $8M | $12M | $11M | $15M | $10M | $4M | |
| Other Non-cash | $149M | · | · | $-114M | $9M | $58M | $146M | $337M | $-57M | $67M | · | $30M | |
| Operating Cash Flow | $-88M | $-68M | $-67M | $-65M | $-56M | $-77M | $-136M | $-124M | $-104M | $-49M | $36M | $-20M | |
| CapEx | $2M | $9M | $2M | $5M | $7M | $8M | $38M | $42M | $47M | $32M | $13M | $6M | |
| Investing Cash Flow | $-2M | $-21M | $-3M | $226M | $-75M | $28M | $87M | $-151M | $104M | $-28M | $-259M | $-26M | |
| Debt Issued | $93M | $0 | $0 | · | $0 | $0 | $376.0K | $220M | $325.0K | $547.0K | $81.0K | $268.0K | |
| Net Debt Issued | $93M | · | · | $-155M | $-466.0K | $-490.0K | $-242.0K | $219M | $-194.0K | $-654.0K | · | $-379.0K | |
| Stock Issued | $-355.0K | $31M | $73M | $0 | · | · | · | · | $0 | $0 | $328M | $0 | |
| Net Stock Activity | $-355.0K | · | · | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $90M | $111M | $30M | $-155M | $121M | $33M | $8M | $310M | $4M | $12M | $332M | $24M | |
| Net Change in Cash | $717.0K | $22M | $-41M | $5M | $-9M | $-16M | $-42M | $35M | $6M | $-66M | $108M | $-22M | |
| Free Cash Flow | $-90M | · | · | $-70M | $-63M | $-85M | $-174M | $-166M | $-151M | $-88M | · | $-26M | |
| Levered FCF | · | · | · | · | · | · | · | $-174M | $-151M | $-88M | · | $-27M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1141.1% | · | · | · | · | · | · | · | -59.7% | -65.6% | · | -97.3% | |
| Net Margin | -2588.2% | · | · | 105.2% | -88.7% | -165.3% | · | · | -50.7% | -97.7% | · | -113.8% | |
| Pretax Margin | -2588.2% | · | · | -297.2% | -93.3% | -100.7% | · | · | -56.1% | -101.7% | · | -119.2% | |
| EBITDA Margin | -1108.1% | · | · | 40.0% | 13.2% | 17.0% | · | · | -46.2% | -52.7% | · | -82.8% | |
| ROA | -166.7% | · | · | 9.8% | -27.3% | -44.3% | -55.0% | -65.2% | -13.0% | -19.3% | · | -15.7% | |
| ROE | 3159.1% | · | · | 21.1% | -77.3% | -271.3% | -148.3% | -113.6% | -21.4% | -29.8% | · | -21.8% | |
| ROIC | -96.9% | · | · | · | · | · | · | -84.5% | -24.9% | -21.6% | · | -17.7% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | · | 1.5 | 4.5 | 3.5 | 1.9 | 4.6 | 1.9 | 3.3 | · | 3.7 | |
| Quick Ratio | 2.7 | · | · | 0.7 | 3.9 | 2.8 | 0.8 | 4.0 | 1.2 | 2.7 | · | 2.7 | |
| Debt / Equity | 4.5 | · | · | 0.3 | 1.7 | 2.6 | 3.0 | 0.6 | 0.0 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 4.5 | · | · | 0.0 | 1.7 | 2.6 | 2.6 | 0.6 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | -59.3 | -225.7 | -145.4 | · | -105.0 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.3 | 0.3 | · | · | 0.3 | 0.2 | · | 0.1 | |
| Receivables Turnover | 4.0 | · | · | 23.4 | 5.6 | 5.6 | · | · | 11.2 | 8.2 | · | 9.4 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.06 | · | · | $0.61 | $0.52 | $0.36 | $0.44 | $2.27 | $4.37 | $4.72 | · | $3.83 | |
| Revenue / Share | $0.03 | · | · | $0.13 | $0.53 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.28 | · | · | $-0.32 | $-0.28 | · | · | · | · | · | · | · | |
| Cash / Share | $0.09 | · | · | $0.02 | $0.21 | $0.28 | $0.40 | $0.64 | $0.56 | $0.53 | · | $0.27 | |
| EPS (TTM) | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 | $-1.02 | $-2.09 | $-1.54 | $-1.54 | $-1.54 | $-0.74 | $-0.84 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | -37.0% | -76.9% | 88.6% | -55.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -28.9% | -35.0% | -42.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -21.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $4M | $6M | $27M | $14M | $32M | $91M | $151M | $231M | $191M | $174M | $72M | |
| Net Income TTM | $-251M | $-126M | $-96M | $28M | $-92M | $-171M | $-322M | $-509M | $-117M | $-187M | $-84M | $-82M | |
| Market Cap | $1.48B | · | · | $316M | $767M | $1.91B | $895M | $1.05B | $1.41B | $2.86B | · | $2.65B | |
| Enterprise Value | $1.47B | · | · | $304M | $835M | $1.99B | $1.04B | $1.04B | $1.34B | $2.63B | · | $2.54B | |
| P/E | -3.1 | -2.4 | -3.4 | 10.9 | -7.9 | -10.0 | -2.6 | -4.2 | -7.5 | -15.6 | -40.4 | -31.3 | |
| P/S | 152.8 | · | · | 11.8 | 53.8 | 59.8 | 9.9 | 6.9 | 6.1 | 15.0 | · | 36.8 | |
| P/B | 70.7 | · | · | 2.5 | 7.1 | 28.5 | 12.5 | 2.9 | 2.6 | 5.1 | · | 6.9 | |
| P / Tangible Book | 592.5 | 8.0 | 6.5 | 7.0 | 43.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | -16.8 | · | · | -4.9 | -13.8 | -24.9 | -6.6 | -8.4 | -13.5 | -51.1 | · | -133.2 | |
| P / FCF | -16.5 | · | · | -4.5 | -12.2 | -22.6 | -5.1 | -6.3 | -9.3 | -32.6 | · | -100.9 | |
| EV / EBITDA | -13.7 | · | · | 28.2 | 60.7 | 113.4 | 41.7 | -2.2 | -12.6 | -26.1 | · | -42.7 | |
| EV / FCF | -16.4 | · | · | -4.3 | -13.3 | -23.5 | -6.0 | -6.2 | -8.9 | -30.0 | · | -96.8 | |
| EV / Revenue | 152.3 | · | · | 11.3 | 58.5 | 62.1 | 11.4 | 6.9 | 5.8 | 13.8 | · | 35.3 | |
| Earnings Yield | -32.8% | -42.0% | -29.1% | 9.2% | -12.7% | -10.0% | -38.1% | -23.5% | -13.4% | -6.4% | -2.5% | -3.2% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55M | $23M | · | · | $856.0K | $1M | · | · | · | · | · | · | $2M | $2M | · | $17M | |
| R&D Expense | $7M | $6M | · | · | $11M | $10M | · | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $22M | $21M | · | · | $16M | $12M | · | · | · | · | · | · | · | · | · | · | |
| Operating Expenses | $32M | $29M | · | · | $33M | $24M | · | · | · | · | · | · | · | · | · | · | |
| Operating Income | $23M | $-6M | · | · | $-32M | $-23M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $16.0K | $290.0K | · | · | $-31.0K | $7.0K | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $20M | $-8M | · | · | $-27M | $-54M | $-20M | $-24M | $-60M | $-24M | $-33M | $-20M | $-20M | $-23M | $-22M | $-8M | |
| Income Tax | $0 | $0 | $0 | $0 | $3.0K | $0 | $-87.0K | $12.0K | $-2M | $-29.0K | $-332.0K | $-6.0K | $-65.0K | $-55.0K | $8.0K | $-50.0K | |
| Net Income | $20M | $-8M | $-24M | $-146M | $-27M | $-54M | $-20M | $-24M | $-59M | $-24M | $-33M | $-20M | $-20M | $-23M | $-22M | $87M | |
| EPS (Basic) | $0.06 | $-0.02 | $-0.04 | $-1.06 | $-0.09 | $-0.18 | $-0.05 | $-0.09 | $-0.23 | $-0.10 | $-0.13 | $-0.08 | $-0.08 | $-0.10 | $-0.11 | $0.44 | |
| EPS (Diluted) | $0.05 | $-0.02 | $-0.04 | $-1.06 | $-0.09 | $-0.18 | $-0.05 | $-0.09 | $-0.23 | $-0.10 | $-0.13 | $-0.08 | $-0.08 | $-0.10 | $-0.11 | $0.44 | |
| Shares (Basic) | 356,893,568 | 354,291,007 | · | 307,170,490 | 296,434,726 | 293,879,653 | · | 275,881,170 | 252,366,533 | 249,220,335 | · | 248,520,724 | 248,003,322 | 229,770,381 | · | 200,670,590 | |
| Shares (Diluted) | 413,686,865 | 354,291,007 | · | 307,170,490 | 296,434,726 | 293,879,653 | · | 275,881,170 | 252,366,533 | 249,220,335 | · | 248,520,724 | 248,003,322 | 229,770,381 | · | 200,670,590 | |
| EBITDA | $23M | $-5M | · | · | · | $629.0K | · | · | · | $2M | · | · | · | $2M | · | · |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $7M | $30M | $14M | $14M | $6M | $30M | $25M | $9M | $17M | · | $10M | $17M | $10M | · | $9M | |
| Short-term Investments | $22M | $49M | $68M | $107M | $46M | $74M | $68M | $4M | $10M | $27M | · | $64M | $72M | $94M | · | $62M | |
| Receivables | $72M | $26M | $4M | $580.0K | $327.0K | $751.0K | $926.0K | $479.0K | $511.0K | $872.0K | · | $988.0K | $1M | $2M | · | $1M | |
| Prepaid Expense | $4M | $4M | $3M | $4M | $2M | $3M | $3M | $5M | $3M | $4M | · | $5M | $3M | $4M | · | $6M | |
| Current Assets | $134M | $102M | $115M | $130M | $63M | $85M | $102M | $35M | $24M | $50M | · | $93M | $106M | $138M | · | $163M | |
| PP&E (Net) | $13M | $13M | $14M | $15M | $15M | $15M | $14M | $14M | $13M | $13M | · | $7M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $38M | $38M | $38M | $38M | $37M | $38M | $37M | $36M | $36M | $37M | · | $31M | $31M | $31M | · | $30M | |
| Accum. Depreciation | $25M | $25M | $24M | $23M | $23M | $23M | $23M | $23M | $22M | $25M | · | $24M | $24M | $24M | · | $23M | |
| Goodwill | $15M | $15M | $15M | $15M | $15M | $19M | $19M | $25M | $25M | $27M | $27M | $37M | $37M | $37M | $37M | $37M | |
| Intangibles | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $39M | · | $40M | $43M | $44M | · | $42M | |
| Other Non-current Assets | $708.0K | $782.0K | $908.0K | $753.0K | $590.0K | $427.0K | $371.0K | $425.0K | $435.0K | $751.0K | · | $797.0K | $949.0K | $1M | · | $871.0K | |
| Total Assets | $170M | $139M | $156M | $171M | $102M | $129M | $145M | $83M | $73M | $135M | · | $191M | $208M | $242M | · | $259M | |
| Accounts Payable | $5M | $3M | $12M | $6M | $4M | $3M | $4M | $4M | $5M | $5M | · | $2M | $3M | $4M | · | $4M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $14M | · | · | |
| Current Liabilities | $29M | $21M | $37M | $32M | $23M | $24M | $22M | $21M | $23M | $29M | · | $33M | $31M | $47M | · | $105M | |
| Capital Leases | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | · | $6M | $7M | $7M | · | $8M | |
| Deferred Tax | · | · | · | · | · | · | · | $89.0K | $77.0K | $2M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Liabilities | $77.0K | $106.0K | $134.0K | $163.0K | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $127M | $118M | $135M | $129M | $108M | $113M | $79M | $28M | $30M | $38M | · | $43M | $41M | $57M | · | $117M | |
| Long-term Debt | $94M | $94M | $93M | $93M | · | · | $0 | · | · | · | · | · | · | · | · | $82M | |
| Total Debt | $94M | $94M | · | · | · | · | · | · | · | · | · | $0 | $0 | $14M | · | $82M | |
| Paid-in Capital | $2.37B | $2.37B | $2.36B | $2.36B | $2.13B | $2.13B | $2.13B | $2.13B | $2.09B | $2.09B | · | $2.08B | $2.08B | $2.08B | · | $2.00B | |
| Retained Earnings | $-2.33B | $-2.35B | $-2.34B | $-2.32B | $-2.17B | $-2.14B | $-2.09B | $-2.07B | $-2.05B | $-1.99B | · | $-1.93B | $-1.91B | $-1.89B | · | $-1.85B | |
| AOCI | $-29.0K | $-17.0K | $7.0K | $24.0K | $11.0K | $12.0K | $12.0K | $13.0K | $-3M | $-3M | · | $-4M | $-3M | $-3M | · | $-7M | |
| Stockholders' Equity | $44M | $20M | $21M | $42M | $-37M | $-14M | $39M | $55M | $43M | $97M | $118M | $148M | $166M | $184M | $126M | $143M | |
| Liabilities + Equity | $170M | $139M | $156M | $171M | $102M | $129M | $145M | $83M | $73M | $135M | · | $191M | $208M | $242M | · | $259M | |
| Shares Outstanding | 358,008,798 | 355,903,977 | 353,910,926 | 353,810,556 | 297,846,160 | 295,135,060 | 292,869,097 | 292,869,097 | 252,656,151 | 250,248,808 | 248,919,096 | 256,398,527 | 255,482,753 | 255,482,753 | 208,150,021 | 208,150,021 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $803.0K | $630.0K | $629.0K | $661.0K | $674.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Stock-based Comp | $4M | $3M | $2M | $4M | $2M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $-89.0K | $12.0K | $-2M | $-29.0K | $-353.0K | $-13.0K | $-58.0K | $-55.0K | $12.0K | $-50.0K | |
| Amort. of Intangibles | $319.0K | $318.0K | $318.0K | $318.0K | $318.0K | $319.0K | $318.0K | $318.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Other Non-cash | · | $-40M | · | · | · | $35M | · | · | · | $6M | · | · | · | $-441.0K | · | · | |
| Operating Cash Flow | $-18M | $-44M | $-23M | $-29M | $-19M | $-16M | $-8M | $-23M | $-23M | $-14M | $-16M | $-17M | $-16M | $-18M | $-15M | $-24M | |
| CapEx | $392.0K | $258.0K | $18.0K | $389.0K | $966.0K | $622.0K | $1M | $882.0K | $2M | $4M | $1M | $236.0K | $101.0K | $154.0K | $53.0K | $2M | |
| Investing Cash Flow | $27M | $21M | $40M | $-63M | $28M | $-6M | $-65M | $6M | $15M | $24M | $13M | $11M | $24M | $-50M | $11M | $182M | |
| Debt Issued | · | · | $-654.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-29M | · | · | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $-355.0K | $-596.0K | $32M | $0 | $0 | $0 | $0 | $-693.0K | $74M | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-355.0K | · | · | · | $0 | · | · | · | $74M | · | · | |
| Financing Cash Flow | $-33.0K | $109.0K | $-514.0K | $93M | $-2M | $-679.0K | $78M | $32M | $52.0K | $0 | $0 | $0 | $-15M | $44M | $-39M | $-116M | |
| Net Change in Cash | $9M | $-23M | $16M | $562.0K | $8M | $-23M | $5M | $15M | $-8M | $10M | $-2M | $-7M | $-7M | $-25M | $-43M | $42M | |
| Free Cash Flow | · | $-44M | · | · | · | $-17M | · | · | · | $-18M | · | · | · | $-19M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.2% | -25.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | 36.5% | -34.1% | · | · | · | · | · | · | · | · | · | · | -1149.9% | -1228.2% | · | 522.5% | |
| Pretax Margin | 36.5% | -34.1% | · | · | · | · | · | · | · | · | · | · | -1153.6% | -1231.2% | · | -46.0% | |
| EBITDA Margin | 41.2% | -21.1% | · | · | · | · | · | · | · | · | · | · | · | 92.4% | · | · | |
| ROA | 14.8% | -5.9% | · | -114.9% | -30.4% | -41.1% | · | -17.5% | -41.9% | -12.6% | · | -8.8% | -7.7% | -7.9% | · | 27.5% | |
| ROE | 590.6% | -256.8% | · | -301.0% | -833.7% | -130.6% | · | -23.6% | -56.2% | -16.9% | · | -13.6% | -18.3% | -17.6% | · | 63.8% | |
| ROIC | 16.5% | -5.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.8 | · | 4.0 | 2.7 | 3.5 | · | 1.6 | 1.0 | 1.7 | · | 2.8 | 3.4 | 2.9 | · | 1.6 | |
| Quick Ratio | 3.8 | 3.9 | · | 3.8 | 2.6 | 3.4 | · | 1.4 | 0.9 | 1.6 | · | 2.3 | 2.9 | 2.3 | · | 0.7 | |
| Debt / Equity | 2.2 | 4.6 | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.1 | · | 0.6 | |
| LT Debt / Equity | 2.2 | 4.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.7 | · | · | · | · | · | · | · | · | · | · | 1.3 | 0.1 | · | 1.6 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $0.06 | · | $0.12 | $-0.12 | $-0.05 | · | $0.19 | $0.17 | $0.39 | · | $0.58 | $0.65 | $0.72 | · | $0.68 | |
| Revenue / Share | $0.13 | $0.07 | · | · | · | · | · | · | · | · | · | · | $0.01 | $0.01 | · | $0.08 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.06 | · | · | · | $-0.06 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.05 | $0.02 | · | $0.04 | $0.05 | $0.02 | · | $0.08 | $0.04 | $0.07 | · | $0.04 | $0.06 | $0.04 | · | $0.04 | |
| EPS (TTM) | $-1.07 | $-1.21 | · | $-1.38 | $-0.41 | $-0.55 | · | $-0.55 | $-0.54 | $-0.39 | · | $-0.37 | $0.15 | $0.14 | · | $0.12 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-158M | $-204M | · | $-247M | $-124M | $-157M | · | $-140M | $-135M | $-97M | · | $-85M | $22M | $25M | · | $25M | |
| Market Cap | $2.04B | $1.38B | · | $1.16B | $423M | $440M | · | $278M | $399M | $363M | · | $364M | $294M | $271M | · | $441M | |
| Enterprise Value | $2.10B | $1.41B | · | · | · | · | · | · | · | · | · | $290M | $205M | $181M | · | $452M | |
| P/E | -5.3 | -3.2 | · | -2.4 | -3.5 | -2.7 | · | -1.7 | -2.9 | -3.7 | · | -3.8 | 7.7 | 7.6 | · | 17.7 | |
| P/B | 46.8 | 68.1 | · | 27.8 | -11.5 | -31.3 | · | 5.0 | 9.2 | 3.7 | · | 2.5 | 1.8 | 1.5 | · | 3.1 | |
| P / Tangible Book | 79.1 | 643.9 | · | 50.3 | · | · | · | 10.8 | 30.3 | 11.4 | · | 5.2 | 3.4 | 2.6 | · | 7.0 | |
| P / Cash Flow | · | -31.4 | · | · | · | -26.9 | · | · | · | -25.8 | · | · | · | -14.7 | · | · | |
| Earnings Yield | -18.8% | -31.3% | · | -41.9% | -28.9% | -36.9% | · | -57.9% | -34.2% | -26.9% | · | -26.1% | 13.0% | 13.2% | · | 5.7% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $10M | $4M | $6M | $27M | $14M |
| Faaliyet Kâr Marjı % | -1141.1% | · | · | · | · |
| Net Gelir | $-251M | $-126M | $-96M | $28M | $-92M |
| Seyreltilmiş Hisse Başı Kâr | $-1.37 | $-0.47 | $-0.39 | $0.14 | $-0.47 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 4.5 | · | · | 0.3 | 1.7 |
| Cari Oran | 3.1 | · | · | 1.5 | 4.5 |
| Cari Oran | 2.7 | · | · | 0.7 | 3.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-90M | · | · | $-70M | $-63M |
Kurumsal Sahipler (13F) 235 dosya · $868.3M toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
235
Tutulan Değer
$868.3M
Yeni pozisyonlar
40
Çıkan pozisyonlar
26
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 40 (-10 önceki Ç'ye göre) | 26 (+10 önceki Ç'ye göre) | 89 (+18 önceki Ç'ye göre) | 46 (-3 önceki Ç'ye göre) | +8.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Patient Capital Management, LLC | $108.510.760 | 19.036.976 | 12,50% | Hisse senetleri |
| BlackRock, Inc. | $97.737.450 | 17.146.921 | 11,26% | Hisse senetleri |
| STATE STREET CORP | $68.414.051 | 12.002.465 | 7,88% | Hisse senetleri |
| Diametric Capital, LP | $52.838.578 | 9.269.926 | 6,09% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $45.065.112 | 7.906.160 | 5,19% | Hisse senetleri |
| VANGUARD GROUP INC | $43.804.109 | 10.479.452 | 5,04% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $36.579.750 | 6.417.500 | 4,21% | Hisse senetleri |
| Boxer Capital Management, LLC | $29.355.000 | 5.150.000 | 3,38% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $28.612.911 | 5.019.028 | 3,30% | Hisse senetleri |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $22.982.189 | 4.031.963 | 2,65% | Hisse senetleri |
| MORGAN STANLEY | $19.776.885 | 3.469.628 | 2,28% | Hisse senetleri |
| Occam Crest Management LP | $19.652.378 | 3.605.941 | 2,26% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $19.416.797 | 3.406.456 | 2,24% | Hisse senetleri |
| FMR LLC | $14.650.046 | 2.570.183 | 1,69% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.603.680 | 2.211.172 | 1,45% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $11.483.556 | 2.014.659 | 1,32% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $10.535.960 | 1.848.414 | 1,21% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $10.192.940 | 1.788.235 | 1,17% | Hisse senetleri |
| NORTHERN TRUST CORP | $10.142.467 | 1.779.380 | 1,17% | Hisse senetleri |
| Caption Management, LLC | $9.690.000 | 1.700.000 | 1,12% | Satım opsiyonu |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.640.362 | 1.515.853 | 1,00% | Hisse senetleri |
| Diametric Capital, LP | $8.048.400 | 1.412.000 | 0,93% | Alım opsiyonu |
| Woodline Partners LP | $7.991.087 | 1.401.945 | 0,92% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $7.386.904 | 1.295.948 | 0,85% | Hisse senetleri |
| Point72 Asset Management, L.P. | $7.220.070 | 1.266.679 | 0,83% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $5.846.205 | 1.025.650 | 0,67% | Hisse senetleri |
| BARCLAYS PLC | $5.308.799 | 931.368 | 0,61% | Hisse senetleri |
| Caption Management, LLC | $5.130.000 | 900.000 | 0,59% | Hisse senetleri |
| JPMORGAN CHASE & CO | $5.077.625 | 849.298 | 0,58% | Hisse senetleri |
| PRELUDE CAPITAL MANAGEMENT, LLC | $5.028.922 | 882.267 | 0,58% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.023.410 | 881.300 | 0,58% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $4.676.217 | 820.389 | 0,54% | Hisse senetleri |
| UBS Group AG | $4.438.949 | 778.763 | 0,51% | Hisse senetleri |
| CITIGROUP INC | $4.131.856 | 724.887 | 0,48% | Hisse senetleri |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $4.025.876 | 706.294 | 0,46% | Hisse senetleri |
| Nuveen, LLC | $4.006.154 | 702.834 | 0,46% | Hisse senetleri |
| GMT Capital Corp | $3.812.331 | 668.830 | 0,44% | Hisse senetleri |
| LexAurum Advisors, LLC | $3.638.954 | 638.413 | 0,42% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $3.450.210 | 605.300 | 0,40% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.430.511 | 601.844 | 0,40% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $3.164.811 | 555.230 | 0,36% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $2.943.091 | 516.332 | 0,34% | Hisse senetleri |
| CIBC Bancorp USA Inc. | $2.849.498 | 499.912 | 0,33% | Hisse senetleri |
| Lansing Street Advisors | $2.823.905 | 495.422 | 0,33% | Hisse senetleri |
| Bank of New York Mellon Corp | $2.704.635 | 474.497 | 0,31% | Hisse senetleri |
| Swiss National Bank | $2.226.420 | 390.600 | 0,26% | Hisse senetleri |
| Cetera Investment Advisers | $2.209.947 | 387.710 | 0,25% | Hisse senetleri |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $2.175.222 | 381.618 | 0,25% | Hisse senetleri |
| PEAK6 LLC | $2.100.450 | 368.500 | 0,24% | Alım opsiyonu |
| Persistent Asset Partners Ltd | $2.027.872 | 355.767 | 0,23% | Hisse senetleri |
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| RANDAL J. KIRK, R.J. KIRK DECLARATION OF TRUST, THIRD SECURITY, LLC ×21 başvurular | 31 Mart 2026 | 35,90% | Değişiklik | · | SEC |
| 06 Ocak 2020 | · | İlk başvuru | · | SEC | |
| 23 Ekim 2017 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 40 içeriden öğrenenler · 16 yöneticiler · 10 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Helen Sabzevari | President and CEO | 23 Ağustos 2026 M | 3.779.521 | 0 | 2 | $-2.562.794 |
| Harry Thomasian Jr. | Chief Financial Officer | 23 Eylül 2026 M | 311.914 | 0 | 4 | $-1.901.756 |
| Rick L. Sterling | Chief Financial Officer | 04 Ocak 2021 M | 340.020 | 0 | 0 | $0 |
| Rutul R Shah | Chief Operating Officer | 25 Ağustos 2026 M | 468.865 | 0 | 6 | $-1.256.398 |
| Thomas Bostick | Chief Operating Officer | 04 Ocak 2020 M | 74.280 | 0 | 0 | $0 |
| Phil Tennant | Chief Commercial Officer | 25 Ağustos 2026 M | 141.992 | 0 | 2 | $-725.731 |
| Donald P. Lehr | Chief Legal Officer | 23 Ağustos 2026 M | 758.181 | 0 | 1 | $-127.011 |
| Jeffrey Thomas Perez | SVP, IP Affairs | 09 Ağustos 2024 P | 743.097 | 0 | 0 | $0 |
| Bradford D. Osborne | VP, Finance and Accounting | 21 Nisan 2021 A | · | 0 | 0 | $0 |
| Thomas D. Reed | Chief Science Officer | 04 Ocak 2020 M | 148.888 | 0 | 0 | $0 |
| Robert F. Walsh III | SVP, Energy & Fine Chem. | 30 Haziran 2019 M | 28.816 | 0 | 0 | $0 |
| Nir Nimrodi | Chief Business Officer | 04 Ocak 2019 A | 19.482 | 0 | 0 | $0 |
| Joel D Liffman | SVP, Finance | 04 Ocak 2019 A | 99.315 | 0 | 0 | $0 |
| Kelly Huang | SVP-Consumer Sector | 09 Mayıs 2014 P | 3.200 | 0 | 0 | $0 |
| Thomas R. Kasser | SVP--Food Sector | 09 Mayıs 2014 P | 15.000 | 0 | 0 | $0 |
| Darryl Webster | SVP--Intellectual Property | 20 Mart 2014 A | 9.132 | 0 | 0 | $0 |
| Jeffrey B Kindler | Yönetim kurulu üyesi | 26 Ağustos 2026 S | 17.100 | 0 | 2 | $-2.231.145 |
| Nancy H Agee | Yönetim kurulu üyesi | 21 Ağustos 2026 P | 309.187 | 1 | 0 | $24.662 |
| RANDAL J. KIRK | Yönetim kurulu üyesi | 30 Mart 2026 S | 12.262.741 | 0 | 25 | $-35.984.076 |
| Vinita D Gupta | Yönetim kurulu üyesi | 13 Mart 2026 M | 666.027 | 0 | 0 | $0 |
| Steven Frank | Yönetim kurulu üyesi | 13 Mart 2026 M | 1.226.391 | 0 | 0 | $0 |
| James S Turley | Yönetim kurulu üyesi | 13 Mart 2026 M | 685.417 | 0 | 0 | $0 |
| Cesar L Alvarez | Yönetim kurulu üyesi | 13 Mart 2026 M | 782.909 | 0 | 0 | $0 |
| Fred Hassan | Yönetim kurulu üyesi | 13 Mart 2026 M | 1.243.239 | 0 | 0 | $0 |
| Dean J Mitchell | Yönetim kurulu üyesi | 14 Mart 2024 A | 503.183 | 0 | 0 | $0 |
| Robert B Shapiro | Yönetim kurulu üyesi | 09 Mart 2023 A | 329.656 | 0 | 0 | $0 |
| Trading S.A. Ares | 10% sahip | 13 Ekim 2021 S | 20.647.152 | 0 | 0 | $0 |
| Andrew J. Last | · | 13 Kasım 2017 P | 4.000 | 0 | 0 | $0 |
| Geno J Germano | · | 22 Eylül 2016 A | · | 0 | 0 | $0 |
| Suma Krishnan | · | 29 Ocak 2016 M | 56.657 | 0 | 0 | $0 |
| Krish S Krishnan | · | 29 Ocak 2016 M | 56.657 | 0 | 0 | $0 |
| Ena Chan Cratsenburg | · | 07 Ocak 2016 A | · | 0 | 0 | $0 |
| INTREXON CORP | · | 07 Ocak 2016 A | · | 0 | 0 | $0 |
| Joseph L Vaillancourt | · | 19 Ekim 2015 A | · | 0 | 0 | $0 |
| Corey Huck | · | 12 Ekim 2015 A | · | 0 | 0 | $0 |
| Samuel Broder | · | 21 Temmuz 2015 A | · | 0 | 0 | $0 |
| Jack A Bobo | · | 20 Temmuz 2015 A | · | 0 | 0 | $0 |
| Olivier Roger Jarry | · | 11 Haziran 2015 A | · | 0 | 0 | $0 |
| Gregory Ian Frost | · | 28 Mayıs 2015 M | 300.000 | 0 | 0 | $0 |
| HORNER LARRY D /FA | · | 12 Mart 2015 A | 68.507 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 29 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,94% | 304.977 NS | 31 Temmuz 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,74% | 1.539.558 NS | 31 Temmuz 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,62% | 17.299 SH | 02 Ekim 2026 | Günlük |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,40% | 198.876 SH | 02 Ekim 2026 | Günlük |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,35% | 765.206 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,31% | 240.763 NS | 31 Temmuz 2026 | N-PORT |
| IWC · iShares Trust | 0,30% | 655.175 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,20% | 25.265 SH | 02 Ekim 2026 | Günlük |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,15% | 139.467 NS | 31 Temmuz 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,09% | 3.289 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,08% | 1.802.964 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,08% | 292.277 SH | 19 Ağustos 2026 | Günlük |
| IBB · iShares Trust | 0,08% | 1.205.825 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 206.995 SH | 19 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 49.171 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 4.946.547 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,04% | 92.222 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 1.111.545 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,02% | 585.833 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 92.500 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 22.110 SH | 11 Eylül 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 10.765 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2.042.450 SH | 19 Ağustos 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 62.200 SH | 09 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 286.766 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.690.796 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 14.522 SH | 19 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 8.008 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 25.549 SH | 11 Eylül 2026 | Günlük |
PGEN Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 9 analist
AL
Medyan hedef
$12.00
+40,5%
2 22,2%
Güçlü Al
5 55,6%
Al
2 22,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
3 analist · 2026-10-01Ortalama hedef $13.65 +59,8%
← Tüm hedeflerin altında
Mevcut fiyat $8.54
Düşük$11.00
Ortalama$13.65
Yüksek$17.95
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 4, 2026